Decolonising vaccine production: Unpacking Ghanaians' support for made-in-Africa vaccines.
Africa
Coronavirus
Decolonising
Nationalism
Vaccines
Journal
Vaccine: X
ISSN: 2590-1362
Titre abrégé: Vaccine X
Pays: England
ID NLM: 101748769
Informations de publication
Date de publication:
Aug 2023
Aug 2023
Historique:
received:
16
09
2022
revised:
24
02
2023
accepted:
14
03
2023
medline:
4
4
2023
entrez:
3
4
2023
pubmed:
4
4
2023
Statut:
epublish
Résumé
Localisation of vaccine production is essential worldwide, but it is particularly crucial for Africa. This continent is more vulnerable to disease burdens and also lags behind other continents regarding access to vaccines. Moreover, many people in Africa have a long-standing apathy towards locally made products and services. This mindset raises the question of whether Africans will support African-made vaccines and what the associated reasons are. Guided by the theories of nationalism and import substitution industrialisation, we formulated and tested eight hypotheses. To answer these, we analysed survey data from 6,731 residents backed by key informant interviews in Ghana. Our findings identified three types of local vaccine consumers:
Identifiants
pubmed: 37008957
doi: 10.1016/j.jvacx.2023.100283
pii: S2590-1362(23)00024-4
pmc: PMC10064421
doi:
Types de publication
Journal Article
Langues
eng
Pagination
100283Informations de copyright
© 2023 The Author(s).
Déclaration de conflit d'intérêts
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Références
Vaccine. 2020 Sep 29;38(42):6609-6617
pubmed: 32788138
BMC Public Health. 2020 Jul 14;20(1):1104
pubmed: 32664891
Bull World Health Organ. 2021 Dec 1;99(12):910-912
pubmed: 34866689
Vaccine X. 2021 Dec;9:100112
pubmed: 34494000
BMC Infect Dis. 2021 Aug 5;21(1):762
pubmed: 34353279
Annu Rev Public Health. 2021 Apr 1;42:175-191
pubmed: 33798403
Soc Sci Med. 2017 Sep;188:109-118
pubmed: 28738317
Lancet Infect Dis. 2021 Jul;21(7):922-923
pubmed: 34174236
Pharm Res. 2019 Mar 11;36(4):63
pubmed: 30859326
Vaccine X. 2022 Feb 11;10:100146
pubmed: 35243322
Trends Pharmacol Sci. 2021 May;42(5):340-353
pubmed: 33773806
Hum Vaccin Immunother. 2022 Dec 31;18(1):1-6
pubmed: 34227914
Hum Vaccin Immunother. 2018 Jul 3;14(7):1599-1609
pubmed: 29617183
Pers Individ Dif. 2021 Jun;175:110706
pubmed: 33551529
Vaccine. 2022 Jul 29;40(31):4081-4089
pubmed: 35654620
PLoS Med. 2007 Mar;4(3):e73
pubmed: 17388657
Vaccine. 2022 Mar 15;40(12):1888-1895
pubmed: 35190209
Bull World Health Organ. 2021 Jul 1;99(7):479-479A
pubmed: 34248217
BMJ. 2022 Jan 31;376:e067367
pubmed: 35101900
Vaccine X. 2022 Aug;11:100162
pubmed: 35492506
Health Res Policy Syst. 2021 Dec 11;19(1):142
pubmed: 34895277
Ann Glob Health. 2016 Nov - Dec;82(6):1010-1025
pubmed: 28314488
Vaccine. 2020 Jan 3;38(1):29-38
pubmed: 31611101
Vaccine X. 2022 Jun 18;11:100184
pubmed: 35800134
BMC Health Serv Res. 2017 Dec 4;17(Suppl 2):696
pubmed: 29219076
Biochem Biophys Res Commun. 2015 Dec 18;468(3):511-7
pubmed: 26518648